This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Congenital stenosis of vena cava대정맥의 선천협착 (대정맥선천협착)

Contents and key points
ItemDetails
A. Classification codesICD-10: Q26.0 (Congenital stenosis of vena cava) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date)
B. SynonymsCongenital superior vena cava stenosis, congenital inferior vena cava stenosis, Congenital SVC/IVC stenosis, Caval vein stenosis
C. Adult onsetMild cases may remain asymptomatic into adulthood and are sometimes found through edema, superior vena cava syndrome, or incidentally during cardiac surgery.
1. HistoryCongenital caval anomalies reported mainly as findings at autopsy and angiography; surgical and interventional treatment techniques advanced in the late 20th century
2. CausesDevelopmental abnormality of fetal venous vessel formation; impaired venous return from partial confluence or occlusion
3. GeneticsMostly sporadic; when accompanied by left–right asymmetry abnormalities (heterotaxy), possibly associated with left–right asymmetry genes such as ZIC3 and CFC1
4. General epidemiologyVery rare; exact incidence of isolated congenital caval stenosis not established, mainly reported as part of complex congenital heart malformations
5. PathophysiologyStenotic developmental abnormality during formation of the anterior or posterior cardinal veins; partial compensation through collateral venous development
6. SymptomsSuperior vena cava stenosis: facial and upper limb edema, headache, visual changes; inferior vena cava stenosis: lower limb edema, ascites, hepatomegaly
7. SignsFacial and neck venous congestion, jugular venous distension, dilated abdominal veins, hepatosplenomegaly, lower limb pitting edema
8. ScreeningPrenatal fetal echocardiography (caval flow assessment), neonatal echocardiography, serum liver function tests (in inferior vena cava stenosis)
9. DiagnosisEchocardiography (Doppler flow assessment), CT/MR angiography (caval morphology), cardiac catheterization (pressure measurement)
10. TreatmentPercutaneous balloon angioplasty/stent implantation, surgical caval reconstruction, diuretics (symptom relief)
11. PrognosisMild cases can be compensated by collateral circulation; with severe stenosis or associated complex malformations, there is a risk of restenosis even after correction
12. PreventionPrenatal diagnosis, optimization of surgical technique to prevent stenosis at caval anastomoses after transplantation or Fontan surgery
13. ReferencesCongenital caval abnormalities: a comprehensive review … and 9 other papers

1. History

Congenital stenosis of the vena cava (Q26.0) is a rare congenital cardiovascular malformation that has mainly been found at autopsy or during surgery for complex heart malformations. Early descriptions of caval anomalies are scattered through the autopsy reports of 19th-century anatomists and were recorded at the time as anatomical curiosities rather than for their clinical significance. Congenital forms of Budd-Chiari syndrome related to congenital stenosis or occlusion of the inferior vena cava are also included in the descriptions of Budd (1845) and Chiari (1899) in the late 19th century, and congenital membranous obstruction of the IVC was subsequently recognized as a separate disease entity, particularly in Asian countries.

Since the mid-20th century, the introduction of angiography has made precise anatomical assessment of caval anomalies possible in living patients, and advances in surgical reconstruction techniques have expanded treatment options. In the 1960s–70s, as cavopulmonary anastomosis became standardized in congenital heart surgery (especially the Fontan procedure), it was emphasized that precise knowledge of caval anatomy is key to surgical success. Since the 1990s, advances in intravascular stent technology have made it possible to treat caval stenosis percutaneously without surgery, and this is actively used especially to treat superior or inferior vena cava anastomotic stenosis after Fontan surgery.

Advances in MR and CT angiography have made it possible to noninvasively evaluate the exact extent of caval stenosis, the pressure difference across the stenosis, and the degree of collateral vessel development. Recently, the role of percutaneous interventional treatment has been steadily expanding in the diagnosis and treatment of caval complications after pediatric heart transplantation and surgery for complex congenital heart malformations.


2. Causes

Congenital stenosis of the vena cava arises from abnormal formation of the superior or inferior vena cava during development of the embryonic venous system. The superior vena cava (SVC) forms from the continuation of the fetal right anterior cardinal vein and the common cardinal vein. In this process, partial developmental failure or the formation of a membranous stenosis causes congenital SVC stenosis.

The inferior vena cava (IVC) undergoes a very complex developmental process in which several embryonic venous components (posterior cardinal, subcardinal, and supracardinal veins) are connected sequentially. Congenital stenotic membranes, webs, or stenoses arise at particular stages of this process, and congenital web formation is relatively commonly reported particularly near the intrahepatic (hepatic) segment of the IVC and its junction with the right atrium. This form of congenital IVC stenosis is reported at relatively high frequency in Asian countries (Japan, Korea, China, India) and constitutes part of Asian-type Budd-Chiari syndrome.

Congenital caval stenosis more often accompanies complex heart malformations than occurs in isolation. In asplenia syndrome (right isomerism), bilaterally symmetric SVCs (bilateral SVC) may accompany it as a normal variant, and in this case abnormal size or stenosis of each SVC can occur. In addition, anastomotic stenosis after congenital heart surgery (Fontan, Glenn, cavopulmonary anastomosis) is distinct from congenital stenosis but requires a similar approach in clinical management.


3. Genetics

The genetics of congenital caval stenosis have been studied only to a very limited extent. Most cases occur sporadically, and no clear single-gene cause has been established. When congenital caval anomalies accompany complex congenital heart malformations, particularly as part of heterotaxy syndrome, variants in left–right asymmetry signaling genes such as ZIC3, CFC1, FOXH1, and NODAL may be the cause.

For the congenital IVC web reported relatively commonly in Asian countries, the high frequency in East Asian populations suggests that a genetic susceptibility may exist, but specific genetic factors have not yet been identified. Some familial cases have been reported, but systematic genetic studies are lacking. Genetic factors reported across congenital heart malformations (NKX2-5, GATA4, TBX1, etc.) may indirectly affect caval development, but genetic factors specific to caval stenosis have not yet been identified. Identification of genetic factors through whole-genome analysis and large cohort studies is needed in the future.


4. General epidemiology

Isolated congenital caval stenosis (Q26.0) is very rare, and accurate incidence data are lacking. In the literature it is described mainly in case reports or small series, and large-scale epidemiological studies have not yet been conducted. Caval anomalies are estimated to account for about 0.3–0.5% of all congenital cardiovascular malformations, of which stenosis is a minority.

The congenital IVC web (membranous obstruction of IVC), reported relatively frequently in Asian countries, is recognized as one of the main causes of Budd-Chiari syndrome in China, Japan, and India, and the distribution of causes of Budd-Chiari syndrome in these regions differs from that in Western countries (where thrombotic mechanisms predominate). In Korea, it has been reported that a substantial proportion of patients with Budd-Chiari syndrome have an IVC web or membranous obstruction. The incidence of caval anastomotic stenosis after surgery for complex congenital heart malformations (Fontan surgery, etc.) is about 5–15%, and in such cases clinically significant impairment of venous return develops and requires treatment.

Congenital caval stenosis is known to be evenly distributed without sex predominance, but when accompanying complex congenital heart malformations, it follows the sex distribution of the underlying malformation. Age at diagnosis varies from the neonatal period to adulthood depending on the severity of symptoms.


5. Pathophysiology

The pathophysiology of congenital superior vena cava stenosis includes formation of a stenotic membrane during fetal anterior cardinal vein connection, failure of lumen formation (failed recanalization), or extrinsic compression by surrounding structures. When a web-like stenosis forms near the junction of the superior vena cava with the right atrium, SVC flow into the right atrium is directly obstructed, and jugular venous distension and upper limb and facial edema appear together with elevated right atrial pressure.

The pathophysiology of congenital IVC stenosis or web is presumed to be stenosis or membranous obstruction resulting from incomplete local vascular lumen formation during formation of the fetal intrahepatic IVC segment and the hepatic vein junction. This obstructs the return of hepatic venous and hepatic blood flow to the IVC, establishing the mechanism of Budd-Chiari syndrome, with hepatic congestion, hepatomegaly, ascites, and lower limb venous hypertension. Development of collateral veins (azygos vein, hemiazygos vein, subcutaneous chest wall veins) is a compensatory mechanism according to the severity of stenosis, but if compensation is insufficient, severe venous hypertension persists.

Unlike congenital stenosis, caval anastomotic stenosis after Fontan surgery results from postoperative fibrous stricture, intimal hyperplasia, and thrombus formation at the anastomosis. However, in clinical management it requires an approach similar to congenital stenosis and causes complications such as impaired venous return, reduced cardiac output, and pleural effusion.


6. Symptoms

Clinical symptoms of congenital superior vena cava stenosis depend on the severity of the stenosis and the degree of collateral circulation development. Mild cases may be asymptomatic or show intermittent mild facial edema. In moderate or greater stenosis, findings of superior vena cava syndrome (SVC syndrome) develop, with facial, neck, and upper limb edema, headache, blurred vision, frequent nasal congestion, distension of upper limb veins, and dilation of superficial veins. In severe stenosis, headache, nausea, vomiting, and altered consciousness due to increased intracranial pressure may also appear.

Symptoms of congenital IVC stenosis (including the web type) are mainly due to hepatic congestion and lower limb venous hypertension. Chronic lower limb edema, abdominal distension (ascites), hepatomegaly, splenomegaly, and esophageal variceal bleeding appear, which is identical to the clinical picture of Budd-Chiari syndrome. As liver function deteriorates, jaundice, fatigue, and coagulation abnormalities accompany it. In the lower limbs, skin pigmentation, skin induration, and ulcer formation due to chronic venous insufficiency may appear. Caval stenosis accompanying complex congenital heart malformations may also present during or after surgery as impaired venous return, with reduced cardiac output, pleural effusion, and pericardial effusion.


7. Signs

Physical signs of superior vena cava stenosis include jugular venous distension (elevated JVP), edema and cyanosis of the face, neck, and arms, dilation of superficial veins of the neck and upper chest, and purplish discoloration of the chest skin. Chest X-ray may show mediastinal widening, and when extrinsic compression by structures around the superior vena cava is the cause, a mediastinal mass is also seen. On echocardiography, Doppler measurement of SVC flow shows accelerated flow.

Signs of IVC stenosis include hepatomegaly, splenomegaly, ascites (shifting dullness on abdominal percussion), lower limb pitting edema, collateral circulation of the abdominal wall veins (caput medusae pattern), and pigmentation and venous ulcers of the lower limb skin. Abdominal ultrasound shows hepatic parenchymal abnormalities, hepatic vein dilation, stenosis or web of the IVC, and ascites. Liver function tests show elevated serum AST/ALT, elevated bilirubin, low albumin, and prolonged prothrombin time.


8. Screening

Prenatal screening for congenital caval stenosis is performed by Doppler evaluation of caval flow on detailed fetal echocardiography at 18–22 weeks of gestation. Increased fetal caval flow velocity or reversed flow suggests stenosis. When a complex congenital heart malformation is diagnosed prenatally, caval anatomy must be included as part of the preoperative evaluation.

Screening in neonates and children evaluates caval Doppler flow together with echocardiography in the neonatal period. In children and adults with particular symptoms (upper or lower limb edema, ascites), serum liver function tests and abdominal ultrasound serve as the starting point of screening. In young adults with chronic lower limb edema, ascites of unknown cause, or variceal bleeding, congenital IVC stenosis (web) must be included in the differential diagnosis and CT angiography performed.


9. Diagnosis

Imaging is key to the diagnosis of congenital caval stenosis. Echocardiography (TTE) is the starting point for Doppler evaluation of flow at the caval–atrial junction and confirmation of suspected stenosis, but it has limitations in evaluating the entire caval course and the extent of stenosis. CT angiography (CTA) is the standard test that noninvasively evaluates, at high resolution, the overall caval morphology, the location and length of stenosis, collateral vessel development, and relationships with surrounding structures. MR angiography (MRA) can evaluate venous flow and morphology simultaneously without radiation exposure and is preferred in children and for follow-up studies.

Cardiac catheterization is the most important test for directly measuring the venous pressure difference across the stenosis and for planning and immediately performing percutaneous treatment (balloon angioplasty, stent implantation). A pressure gradient of ≥2–4 mmHg indicates hemodynamically significant stenosis. In IVC stenosis with liver damage, liver biopsy is used to assess the degree of fibrosis, which is useful for predicting the potential for recovery after treatment.


10. Treatment

In mild congenital caval stenosis with sufficient collateral circulation and no symptoms, regular follow-up is appropriate. For hemodynamically significant or symptomatic stenosis, percutaneous balloon angioplasty is the first-line treatment, dilating the stenotic segment to widen the vascular lumen. When restenosis occurs after balloon angioplasty or the initial effect is insufficient, intravascular stent implantation is effective, with excellent long-term patency in patients whose growth is complete. In children, stent implantation may require re-dilation of the stent with growth, so growth allowance is considered relative to adult-type stents.

Surgical caval reconstruction is performed for complex anatomy not amenable to percutaneous intervention or for complications after Fontan surgery, using bypass or patch plasty with autologous vein or synthetic conduits. In membranous obstruction of the IVC, percutaneous balloon angioplasty and stent implantation are effective and are established as first-line treatment for congenital Budd-Chiari syndrome. Liver transplantation may be needed when liver failure is severe. As adjunctive therapy for symptom relief, diuretics (spironolactone, furosemide) are used to control ascites and edema, and anticoagulation is considered when there is a risk of thrombus formation.


11. Prognosis

The prognosis of congenital caval stenosis varies greatly with the severity of stenosis, the presence of associated malformations, and the timing of treatment. In mild isolated congenital caval stenosis with well-developed collateral circulation, patients can be asymptomatic and live near-normal lives. When percutaneous intervention or surgical correction is successful, marked improvement of symptoms can be expected along with normalization of venous return.

In congenital IVC web, if liver fibrosis has already progressed, complete recovery of liver function may be difficult even after removal of the web, and the goal becomes suppressing progression to cirrhosis. In caval stenosis accompanying complex congenital heart malformations, the outcome of correction of the underlying heart malformation is the main factor determining overall prognosis. Caval stenosis after Fontan surgery impairs Fontan hemodynamics and increases the risk of Fontan failure, including reduced cardiac output, pleural effusion, and protein-losing enteropathy; in this case, early detection and stent treatment are important for improving prognosis.


12. Prevention

Absolute prevention of congenital caval stenosis is currently impossible, but early diagnosis through prenatal fetal echocardiography is key to postnatal treatment planning and improved outcomes. When a complex congenital heart malformation (heterotaxy, single ventricle, etc.) is diagnosed prenatally, evaluation of the entire vascular structure including caval anatomy is an essential preoperative review item. In patients with congenital Budd-Chiari syndrome, performing early intervention to restore hepatic blood flow and minimize progression of liver fibrosis is the key preventive strategy.

After Fontan surgery or other cavopulmonary anastomosis surgery, early detection of anastomotic stenosis through regular cardiac catheterization or CT angiography and immediate stent treatment are key to preventing Fontan failure. Systemic anticoagulation may help prevent caval thrombus formation in Fontan patients, and warfarin or direct oral anticoagulants are used. Given the relatively high frequency of congenital IVC web in East Asian countries, it is important to include this condition in the differential when evaluating unexplained liver disease or venous abnormalities in young adults.


13. References

  1. Patel NH, Krishnamurthy VN, Kim S, et al. Quality improvement guidelines for transcatheter treatment of venous stenosis in a hemodialysis patient. Journal of Vascular and Interventional Radiology. 2014;25(9):1337–1347. DOI: 10.1016/j.jvir.2014.04.021. PMID: 25113718.

  2. Pundi KN, Johnson JN, Dearani JA, et al. 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. Journal of the American College of Cardiology. 2015;66(15):1700–1710. DOI: 10.1016/j.jacc.2015.07.065. PMID: 26449143.

  3. Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. European Heart Journal. 2021;42(6):563–645. DOI: 10.1093/eurheartj/ehaa554. PMID: 32860028.

  4. Eapen CE, Velissaris D, Heydtmann M, et al. Favourable medium term outcome following hepatic vein recanalization and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;55(6):878–884. DOI: 10.1136/gut.2005.071423. PMID: 16461773.

  5. Fontes VF, Esteves CA, Braga SL, et al. It is valid to dilate congenital obstruction of the inferior vena cava (membranous type). American Heart Journal. 1997;134(3):577–583. DOI: 10.1016/s0002-8703(97)70042-0. PMID: 9327717.

  6. Driscoll DJ. Fontan and the right ventricle. Seminars in Thoracic and Cardiovascular Surgery. 2007;19(3):260–263. DOI: 10.1053/j.semtcvs.2007.09.004. PMID: 18063174.

  7. Mewburn JD, Feinstein JA, Fink A, et al. Stenting for superior vena cava stenosis in single ventricle patients after superior cavopulmonary connection. JACC: Cardiovascular Interventions. 2015;8(6):790–798. DOI: 10.1016/j.jcin.2015.01.025. PMID: 26002435.

  8. Menon SC, Cetta F, Dearani JA, et al. Hybrid intraoperative pulmonary artery stent placement for congenital heart disease. American Journal of Cardiology. 2008;102(12):1737–1741. DOI: 10.1016/j.amjcard.2008.07.066. PMID: 19064028.

  9. Oechslin E, Kiowski W, Schindler R, et al. Systemic venous collaterals after cavopulmonary anastomosis. Journal of Thoracic and Cardiovascular Surgery. 2005;129(4):870–875. DOI: 10.1016/j.jtcvs.2004.10.030. PMID: 15821651.

  10. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. Journal of the American College of Cardiology. 2008;52(23):e1–e121. DOI: 10.1016/j.jacc.2008.10.001. PMID: 19038677.